Eli Lily caps the cost of insulin at $35 a month, bringing relief to millions of Americans.

(Credit: George Frey—Reuters)

Key takeaways

• As insulin prices have risen, 16.5% of users have rationed the drug to get by
• Eli Lilly, a major insulin manufacturing company, announced Wednesday it will cut insulin prices by 70% 
• The producer will further cap out-of-pocket monthly costs by $35 through their “Insulin Value Program”

Eli Lilly plans to cut costs on their most common insulin products by 70%, the company announced in a press release Wednesday.